Spontaneous remission in myelodysplastic syndrome

Annals of Hematology

Volumn 78, Issue 2, 1999, Pages 89-90

  Dervenoulas, J G ^a   Tsirigotis, P ^a   Bollas, G ^a   Pappa, V ^a   Raptis, S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Myelodysplastic syndrome; RAEB; Spontaneous remission

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CYTOKINE;

AGED; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ANALYSIS; ERYTHROCYTE CONCENTRATE; HOSPITALIZATION; HUMAN; HUMAN CELL; KARYOTYPE; MALE; METAPHASE; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; REMISSION; RESPIRATORY TRACT INFECTION; TRISOMY 21;

AGED; AMIKACIN; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BONE MARROW; CEFTAZIDIME; CHROMOSOMES, HUMAN, PAIR 21; CYTOKINES; DRUG THERAPY, COMBINATION; HUMANS; MALE; PNEUMONIA, BACTERIAL; RECURRENCE; REMISSION, SPONTANEOUS; TRISOMY;

EID: 0033031285     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050479     Document Type: Article

References (14)

1. Belanger R, Gyger M, et al (1988) Bone marrow transplantation for myelodysplastic syndromes. Br J Haematol 69:29-33
2. De Witte T, Zwaan F, Hermans J, et al (1990) Allogeneic bone marrow transplantation for secondary leukemia and myelodysplastic syndrome: a survey by the leukemia Working Party of the EBMTG. Br J Haematol 74:151-155
3. Estey E, et al (1993) Treatment of myelodysplastic syndromes with AML-type chemotherapy. Leukemia Lymphoma 11 [Suppl 2]: 59-63
4. Greenberg P, Taylor K, Larson R, et al (1993) Phase II randomised multicenter trial of G-CSF vs observation for MDS. Blood [Suppl 1]:196a
5. Greenberg P, Cox C, Le Beau MM, et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088
6. Hellstrom-Lindberg E (1995) Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. Br J Haematol 89:67
7. Levine EG, Bloomfield CD (1992) Leukemia and myelodysplastic syndromes secondary to drug, radiation and environmental exposure. Semin Oncol 19:47
8. Musashi M, Abe S, Yamada T, Tanaka J, Gotohda Y, Maeda S, Sato Y, Morioka M, Sakurada K, Minagawa T, Asaka M and Miyazaki T (1997) Spontaneous remission in a patient with chronic myelogenous leukemia. N Engl J Med 336:337-339
9. Provan AB, Majer RV, Herbert A, Smith AG (1991) Spontaneous remission of chronic myeloid leukemia with loss of the Philadelphia chromosome. Br J Haematol 78:578-579
10. Smadja N, Krulik M, Audebert AA, de Gramont A, Debray J (1986) Spontaneous regression of cytogenetic and haematologic anomalies in Phl-positive chronic myelogenous leukaemia. Br J Haematol 63:257-262
11. Talpaz M, McCredie KB, Mavligit GM, Gutterman JU (1983) Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood 62:689-692
12. Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N Engl J Med 314:1065-1069
13. Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU (1991) Interferon alpha in the therapy of CML. Br J Haematol 79 [Suppl 1]: 38-41
14. Wiernik PH (1976) Spontaneous regression of hematologic cancers. In: Lewison EF (ed) Conference on spontaneous regression of cancer. National Cancer Institute monograph 44.: Government Printing Office, Washington, D.C., 35-8. (DHEW publication no. (NIH) 76-1038)